Wealth Enhancement Advisory Services
EBS icon

Wealth Enhancement Advisory Services’s Emergent Biosolutions EBS Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$198K Buy
24,603
+6,024
+32% +$50.4K ﹤0.01% 3594
2026
Q1 		$153K Buy
18,579
+5,563
+43% +$57.6K ﹤0.01% 3223
2025
Q4 		$171K Buy
13,016
+1,625
+14% +$17.4K ﹤0.01% 3315
2025
Q3 		$113K Buy
+11,391
New +$88.6K ﹤0.01% 3310

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Wealth Enhancement Advisory Services's EBS Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Emergent Biosolutions (EBS) stake by 32% in Q2 2026, buying an estimated $50.4K and bringing the position to 24,603 shares worth $198K. The position accounts for ﹤0.01% of the portfolio, ranked #3594.

Wealth Enhancement Advisory Services first reported a position in EBS in Q3 2025 and has held it in 4 quarters since. 194 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Wealth Enhancement Advisory Services held 24,603 shares of Emergent Biosolutions worth $198K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 6,024 Emergent Biosolutions shares in Q2 2026, an estimated $50.4K.
  • Emergent Biosolutions made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3594 holding.
  • Wealth Enhancement Advisory Services first reported a position in Emergent Biosolutions in Q3 2025 and has held it in 4 quarters since.
  • 194 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.